Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS) (Q37219274)
Jump to navigation
Jump to search
scientific article published on 12 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS) |
scientific article published on 12 February 2009 |
Statements
1 reference
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS) (English)
1 reference
Alan T Remaley
1 reference
Kennichi C Dowdell
1 reference
Lesley Pesnicak
1 reference
Victoria Hoffmann
1 reference
Kenneth Steadman
1 reference
Jeffrey I Cohen
1 reference
Stephen E Straus
1 reference
V Koneti Rao
1 reference
12 February 2009
1 reference
1 reference
487-494
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference